Additional important research priorities for bronchiectasis in China

Abstract

We highly appreciate the laudable desire of the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) [1] to provoke research interests and develop study protocols to investigate bronchiectasis, a disease which has not yet received sufficient attention worldwide, particularly in China. China is a major developing country with a large population; however, there is a lack of epidemiological investigations detailing the prevalence or incidence of bronchiectasis. While we totally concur with the recommendations from European experts, we feel that additional priorities in bronchiectasis should be highlighted for future research in China.